Datamonitor

Showing 3 posts of 3 posts found.

Slow recovery expected for epilepsy market

May 27, 2010
Sales and Marketing Datamonitor, Keppra, UCB, epilepsy

The global market for epilepsy treatments is expected to make a slow recovery after a wave of patent expiries from …

Drug repositioning a ‘key strategy’ for pharma

July 17, 2009
Research and Development Datamonitor, strategy

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …

Little benefit to pharma from G20 initiatives

April 22, 2009
Research and Development, Sales and Marketing Datamonitor, strategy

Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …

The Gateway to Local Adoption Series

Latest content